Liftstream is an executive search recruitment company in the life sciences sector
Sutro Biopharma signs $1bn deal with Celgene
Authored by James Sheppard
Executive Recruitment Roundup – Biotechnology – June 2014
Authored by Karl Simpson
Posted in Executive Appointments, Pharmaceutical business
Tagged 3M, ADCs, Amgen, Annalisa jenkins, Avila Therapeutics, Biothera, celgene, Daniel Elger, David Meline, e-therpaeutics, Editas Medicine, Frank Thomas, General Motors, Genkyotex, Katrine Bosley, Keith Wilson, Kymab, Merck Serono, Nigel Clarke, Oxford Biotherapeutics, Steven Arkinstall, Third Rock Ventures, TransCelerate, Zafgen
Leave a comment
AnaptysBio expands its cancer immunotherapy portfolio
Authored by Karl Simpson
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases
Tagged ADCs, AHM-XEL, AnaptysBio, ANB011, anti PD1, Antibodies, Avalon Ventures, cancer, Celltech, Cimzia, David King, fibrosis, GSK, Hamza Suria, immunotherapy, inflammation, LAG-3, Maxygen, oncology, somatic hypermutation, TIM-3, UCB, UK
Leave a comment
Seattle Genetics strike another alliance deal with Bayer
Authored by Karl Simpson
Posted in M&A Finance and Funding, Pharmaceutical business
Tagged ADCETRIS, ADCs, alliance, Antibody-drug conjugates, ASCO, Bayer, FDA, Immunogen, innovator, Kadcyla, Lymphoma, oncology, pharmaceutical, Roche, seattle genetics, Takeda
Leave a comment
Seattle Genetics delivers more ammunition for ADCs in cancer fight
Authored by Karl Simpson
Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged ADCETRIS, ADCs, anaplastic large cell lymphoma, anti-CD30, Antibody-drug conjugates, ASCO, CD30-expressing tumour cells, Hodgkin Lymphoma, mature T-cell lymphoma, monoclonal antibody, MTCL, seattle genetics, Takeda
Leave a comment